31 – 40 of 168
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
European Task Force on Atopic Dermatitis (ETFAD) : treatment targets and treatable traits in atopic dermatitis
(
- Contribution to journal › Letter
-
Mark
Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic
(
- Contribution to journal › Article
-
Mark
Hidradenitis Suppurativa in Sweden : A Registry-Based Cross-Sectional Study of 13,538 Patients
(
- Contribution to journal › Article
-
Mark
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis
(
- Contribution to journal › Letter
-
Mark
Subjective and Objective Characteristics of Patients Seen at a Psychodermatology Unit : One-year Experience in Malmö, Sweden
(
- Contribution to journal › Article
-
Mark
Tocilizumab-induced sarcoidosis-like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon
(
- Contribution to journal › Letter
-
Mark
TREatment of ATopic eczema (TREAT) Registry Taskforce : protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
(
- Contribution to journal › Article
-
Mark
Associations of self-reported atopic dermatitis with comorbid conditions in adults : a population-based cross-sectional study
(
- Contribution to journal › Article
-
Mark
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
(
- Contribution to journal › Article
-
Mark
Itch and Mental Health in Dermatological Patients across Europe : A Cross-Sectional Study in 13 Countries
(
- Contribution to journal › Article